Logo image of BAS.DE

BASF SE (BAS.DE) Stock Fundamental Analysis

FRA:BAS - Deutsche Boerse Ag - DE000BASF111 - Common Stock - Currency: EUR

54.62  +0.07 (+0.13%)

Fundamental Rating

4

BAS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 61 industry peers in the Chemicals industry. BAS has an average financial health and profitability rating. BAS has a valuation in line with the averages, but on the other hand it scores bad on growth. BAS also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BAS was profitable.
In the past year BAS had a positive cash flow from operations.
In multiple years BAS reported negative net income over the last 5 years.
Of the past 5 years BAS 4 years had a positive operating cash flow.
BAS.DE Yearly Net Income VS EBIT VS OCF VS FCFBAS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.63%, BAS is in line with its industry, outperforming 53.97% of the companies in the same industry.
BAS has a Return On Equity (1.43%) which is in line with its industry peers.
The Return On Invested Capital of BAS (1.46%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for BAS is in line with the industry average of 6.72%.
The 3 year average ROIC (6.22%) for BAS is well above the current ROIC(1.46%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.63%
ROE 1.43%
ROIC 1.46%
ROA(3y)1.96%
ROA(5y)2.85%
ROE(3y)4.2%
ROE(5y)5.95%
ROIC(3y)6.22%
ROIC(5y)4.66%
BAS.DE Yearly ROA, ROE, ROICBAS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

BAS has a Profit Margin (0.76%) which is in line with its industry peers.
In the last couple of years the Profit Margin of BAS has declined.
The Operating Margin of BAS (1.99%) is comparable to the rest of the industry.
BAS's Operating Margin has declined in the last couple of years.
BAS's Gross Margin of 25.54% is in line compared to the rest of the industry. BAS outperforms 46.03% of its industry peers.
BAS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.99%
PM (TTM) 0.76%
GM 25.54%
OM growth 3Y69.71%
OM growth 5Y-14.34%
PM growth 3YN/A
PM growth 5Y-47.01%
GM growth 3Y-2.33%
GM growth 5Y-3.7%
BAS.DE Yearly Profit, Operating, Gross MarginsBAS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

4

2. Health

2.1 Basic Checks

BAS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BAS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BAS.DE Yearly Shares OutstandingBAS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M
BAS.DE Yearly Total Debt VS Total AssetsBAS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B

2.2 Solvency

BAS has an Altman-Z score of 2.36. This is not the best score and indicates that BAS is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.36, BAS is in the better half of the industry, outperforming 60.32% of the companies in the same industry.
BAS has a debt to FCF ratio of 12.32. This is a negative value and a sign of low solvency as BAS would need 12.32 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.32, BAS is in line with its industry, outperforming 52.38% of the companies in the same industry.
BAS has a Debt/Equity ratio of 0.55. This is a neutral value indicating BAS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.55, BAS perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 12.32
Altman-Z 2.36
ROIC/WACC0.27
WACC5.49%
BAS.DE Yearly LT Debt VS Equity VS FCFBAS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

2.3 Liquidity

BAS has a Current Ratio of 1.87. This is a normal value and indicates that BAS is financially healthy and should not expect problems in meeting its short term obligations.
BAS has a Current ratio (1.87) which is comparable to the rest of the industry.
BAS has a Quick Ratio of 1.03. This is a normal value and indicates that BAS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.03, BAS is in line with its industry, outperforming 49.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.03
BAS.DE Yearly Current Assets VS Current LiabilitesBAS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.53% over the past year.
Measured over the past years, BAS shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.88% on average per year.
EPS 1Y (TTM)10.53%
EPS 3Y-23.02%
EPS 5Y-4.88%
EPS Q2Q%185.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.47%

3.2 Future

BAS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.80% yearly.
Based on estimates for the next years, BAS will show a small growth in Revenue. The Revenue will grow by 4.61% on average per year.
EPS Next Y17.88%
EPS Next 2Y18.97%
EPS Next 3Y10.45%
EPS Next 5Y9.8%
Revenue Next Year3.18%
Revenue Next 2Y3.85%
Revenue Next 3Y4.76%
Revenue Next 5Y4.61%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
BAS.DE Yearly Revenue VS EstimatesBAS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B
BAS.DE Yearly EPS VS EstimatesBAS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.73, which indicates a rather expensive current valuation of BAS.
Compared to the rest of the industry, the Price/Earnings ratio of BAS indicates a rather cheap valuation: BAS is cheaper than 80.95% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, BAS is valued a bit cheaper.
The Price/Forward Earnings ratio is 15.02, which indicates a correct valuation of BAS.
Based on the Price/Forward Earnings ratio, BAS is valued a bit cheaper than 68.25% of the companies in the same industry.
BAS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.73
Fwd PE 15.02
BAS.DE Price Earnings VS Forward Price EarningsBAS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

63.49% of the companies in the same industry are more expensive than BAS, based on the Enterprise Value to EBITDA ratio.
61.90% of the companies in the same industry are more expensive than BAS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 26.92
EV/EBITDA 10.5
BAS.DE Per share dataBAS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

BAS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.99
PEG (5Y)N/A
EPS Next 2Y18.97%
EPS Next 3Y10.45%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.12%, BAS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.89, BAS pays a better dividend. On top of this BAS pays more dividend than 85.71% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, BAS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

The dividend of BAS has a limited annual growth rate of 2.25%.
Dividend Growth(5Y)2.25%
Div Incr Years0
Div Non Decr Years3
BAS.DE Yearly Dividends per shareBAS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

646.39% of the earnings are spent on dividend by BAS. This is not a sustainable payout ratio.
The dividend of BAS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP646.39%
EPS Next 2Y18.97%
EPS Next 3Y10.45%
BAS.DE Yearly Income VS Free CF VS DividendBAS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B
BAS.DE Dividend Payout.BAS.DE Dividend Payout, showing the Payout Ratio.BAS.DE Dividend Payout.PayoutRetained Earnings

BASF SE

FRA:BAS (3/6/2025, 5:18:53 PM)

54.62

+0.07 (+0.13%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-28 2025-02-28/bmo
Earnings (Next)05-02 2025-05-02/bmo
Inst Owners26.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.75B
Analysts74.84
Price Target55.49 (1.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend3.46
Dividend Growth(5Y)2.25%
DP646.39%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.3%
Min EPS beat(2)-52.95%
Max EPS beat(2)10.34%
EPS beat(4)2
Avg EPS beat(4)-40.02%
Min EPS beat(4)-140.92%
Max EPS beat(4)23.46%
EPS beat(8)3
Avg EPS beat(8)-27.93%
EPS beat(12)6
Avg EPS beat(12)-15.76%
EPS beat(16)10
Avg EPS beat(16)-9.3%
Revenue beat(2)1
Avg Revenue beat(2)-1.49%
Min Revenue beat(2)-4.39%
Max Revenue beat(2)1.4%
Revenue beat(4)1
Avg Revenue beat(4)-3.04%
Min Revenue beat(4)-4.97%
Max Revenue beat(4)1.4%
Revenue beat(8)1
Avg Revenue beat(8)-5.2%
Revenue beat(12)5
Avg Revenue beat(12)-2.2%
Revenue beat(16)9
Avg Revenue beat(16)0.02%
PT rev (1m)1.6%
PT rev (3m)2.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)49.05%
EPS NY rev (1m)-0.55%
EPS NY rev (3m)-0.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.62%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-0.78%
Valuation
Industry RankSector Rank
PE 17.73
Fwd PE 15.02
P/S 0.75
P/FCF 26.92
P/OCF 6.29
P/B 1.4
P/tB 2.12
EV/EBITDA 10.5
EPS(TTM)3.08
EY5.64%
EPS(NY)3.64
Fwd EY6.66%
FCF(TTM)2.03
FCFY3.71%
OCF(TTM)8.69
OCFY15.9%
SpS73.13
BVpS38.92
TBVpS25.8
PEG (NY)0.99
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.63%
ROE 1.43%
ROCE 2.08%
ROIC 1.46%
ROICexc 1.53%
ROICexgc 1.9%
OM 1.99%
PM (TTM) 0.76%
GM 25.54%
FCFM 2.77%
ROA(3y)1.96%
ROA(5y)2.85%
ROE(3y)4.2%
ROE(5y)5.95%
ROIC(3y)6.22%
ROIC(5y)4.66%
ROICexc(3y)6.5%
ROICexc(5y)4.87%
ROICexgc(3y)8.24%
ROICexgc(5y)6.18%
ROCE(3y)8.83%
ROCE(5y)6.61%
ROICexcg growth 3Y78.18%
ROICexcg growth 5Y-13%
ROICexc growth 3Y79.2%
ROICexc growth 5Y-11.48%
OM growth 3Y69.71%
OM growth 5Y-14.34%
PM growth 3YN/A
PM growth 5Y-47.01%
GM growth 3Y-2.33%
GM growth 5Y-3.7%
F-Score6
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 12.32
Debt/EBITDA 2.96
Cap/Depr 115.72%
Cap/Sales 9.1%
Interest Coverage 250
Cash Conversion 120.54%
Profit Quality 363.66%
Current Ratio 1.87
Quick Ratio 1.03
Altman-Z 2.36
F-Score6
WACC5.49%
ROIC/WACC0.27
Cap/Depr(3y)103.05%
Cap/Depr(5y)89.23%
Cap/Sales(3y)5.78%
Cap/Sales(5y)5.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.53%
EPS 3Y-23.02%
EPS 5Y-4.88%
EPS Q2Q%185.47%
EPS Next Y17.88%
EPS Next 2Y18.97%
EPS Next 3Y10.45%
EPS Next 5Y9.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.47%
Revenue Next Year3.18%
Revenue Next 2Y3.85%
Revenue Next 3Y4.76%
Revenue Next 5Y4.61%
EBIT growth 1Y-58.55%
EBIT growth 3Y78.57%
EBIT growth 5Y-12%
EBIT Next Year103.06%
EBIT Next 3Y36.42%
EBIT Next 5Y21.99%
FCF growth 1Y-29.78%
FCF growth 3Y5.82%
FCF growth 5Y-7.66%
OCF growth 1Y17.99%
OCF growth 3Y14.38%
OCF growth 5Y0.43%